Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type
Condition(s) studied
Investigational drug(s) / intervention(s)
Endoscopic submucosal dissection: Endoscopic submucosal dissection by a endoscopist using endoscopic devices
Surgery: Gastrectomy with lymph node dissection by a surgeon
Study summary
This multi-center, randomized controlled trial is designed to evaluate clinical effectiveness and cost-effectiveness of ESD for undifferentiated type of EGC meeting the expanded indication compared with surgery.
Eligibility
Primary outcome measure(s)
- 3-year disease-free survival in the ITT population — 3 years after the last participant enrollment
Disease-free survival (gastric cancer recurrence or death from any causes)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| National Cancer Center, Korea | Goyang-si | Gyeonggi-do | Recruiting |
More National Cancer Center, Korea trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04890171 on ClinicalTrials.gov ↗ ← All trials in South Korea